Explore
Validate
Learn
Immunocytochemistry
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- V2077 - Provider product page
- Provider
- NSJ Bioreagents
- Product name
- CD74 Antibody
- Antibody type
- Monoclonal
- Antigen
- SU-DHL-4 lymphoma cells were used as the immunogen for this CD74 antibody.
- Description
- Protein G purified antibody
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antibody clone number
- LN-2
- Vial size
- 20 µg, 100 µg (with sodium azide), 100 µg (without sodium azide), 7 ml (prediluted for IHC use, if applicable)
- Storage
- Store the CD74 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
Submitted references CD74 interferes with the expression of fas receptor on the surface of lymphoma cells.
Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates.
MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling.
The role of macrophage migration inhibitory factor in autoimmune liver disease.
TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas.
LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma.
Berkova Z, Wang S, Ao X, Wise JF, Braun FK, Rezaeian AH, Sehgal L, Goldenberg DM, Samaniego F
Journal of experimental & clinical cancer research : CR 2014 Oct 10;33:80
Journal of experimental & clinical cancer research : CR 2014 Oct 10;33:80
Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates.
Capone S, Naddeo M, D'Alise AM, Abbate A, Grazioli F, Del Gaudio A, Del Sorbo M, Esposito ML, Ammendola V, Perretta G, Taglioni A, Colloca S, Nicosia A, Cortese R, Folgori A
Molecular therapy : the journal of the American Society of Gene Therapy 2014 May;22(5):1039-47
Molecular therapy : the journal of the American Society of Gene Therapy 2014 May;22(5):1039-47
MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling.
Klasen C, Ohl K, Sternkopf M, Shachar I, Schmitz C, Heussen N, Hobeika E, Levit-Zerdoun E, Tenbrock K, Reth M, Bernhagen J, El Bounkari O
Journal of immunology (Baltimore, Md. : 1950) 2014 Jun 1;192(11):5273-84
Journal of immunology (Baltimore, Md. : 1950) 2014 Jun 1;192(11):5273-84
The role of macrophage migration inhibitory factor in autoimmune liver disease.
Assis DN, Leng L, Du X, Zhang CK, Grieb G, Merk M, Garcia AB, McCrann C, Chapiro J, Meinhardt A, Mizue Y, Nikolic-Paterson DJ, Bernhagen J, Kaplan MM, Zhao H, Boyer JL, Bucala R
Hepatology (Baltimore, Md.) 2014 Feb;59(2):580-91
Hepatology (Baltimore, Md.) 2014 Feb;59(2):580-91
TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas.
Griewank KG, Schilling B, Murali R, Bielefeld N, Schwamborn M, Sucker A, Zimmer L, Hillen U, Schaller J, Brenn T, Schadendorf D, Mentzel T
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2014 Apr;27(4):502-8
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2014 Apr;27(4):502-8
LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma.
Lazova R, Moynes R, May D, Scott G
Cancer 1997 Jun 1;79(11):2115-24
Cancer 1997 Jun 1;79(11):2115-24
No comments: Submit comment
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC testing of human tonsil with CD74 antibody (LN-2).
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC testing of human tonsil with CD74 antibody (LN-2)
